SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.

Income Statement Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Equities

300760

CNE100003G67

Advanced Medical Equipment & Technology

End-of-day quote Shenzhen S.E. Other stock markets 2025-12-16			5-day change	1st Jan Change
194.81 ^CNY	-1.12%		-1.96%	-23.60%

11-10	Mindray Bio-Medical Electronics submits application for Hong Kong listing	RE
11-05	Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Approves Cash Dividend on A Shares for the Year 2025 for the Third Quarter of 2025, Payable on November 12, 2025	CI

c690b1a42c300520a15f12d1cf.Oe6W4qIOog5aRno5nyq_dJ4G7nJGvgMQg9Iu8DZPfQ4.CdnwocFK-ngNJS8J1Bn6Pah0ujkQ3Ftj6J4dl0wrHmJsw-CN2GjWOQ4kMw

Published financial data: SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	20.98B	25.26B	30.35B	34.88B	36.62B
Other Revenues, Total	44.89M	11.73M	11.83M	56.61M	102M
Total Revenues	21.03B	25.27B	30.37B	34.93B	36.73B
Cost of Goods Sold, Total	7.46B	8.97B	10.96B	12.08B	13.77B
Gross Profit	13.57B	16.3B	19.41B	22.86B	22.96B
Selling General & Admin Expenses, Total	4.51B	5.1B	6.12B	7.23B	6.88B
Provision for Bad Debts	29.7M	-6.68M	37.14M	245M	299M
R&D Expenses	1.87B	2.52B	2.92B	3.43B	3.67B
Other Operating Expenses	-101M	-83.14M	-80.36M	-309M	-262M
Other Operating Expenses, Total	6.31B	7.54B	9B	10.6B	10.59B
Operating Income	7.26B	8.76B	10.41B	12.26B	12.37B
Interest Expense, Total	-	-8.63M	-10.69M	-13M	-19.41M
Interest And Investment Income	386M	407M	358M	822M	627M
Net Interest Expenses	386M	399M	347M	809M	607M
Income (Loss) On Equity Invest.	-4.47M	811K	-	-	-
Currency Exchange Gains (Loss)	-253M	-228M	172M	119M	-51.28M
Other Non Operating Income (Expenses)	-70.86M	-85.92M	-67.82M	-72.51M	-87.45M
EBT, Excl. Unusual Items	7.32B	8.85B	10.86B	13.12B	12.84B
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	9.88M	-26.44M	69.56M	109M
Gain (Loss) On Sale Of Assets	-2.07M	4.07M	6.16M	2.46M	4.24M
Asset Writedown	-16.87M	-7.47M	-740K	-275M	-1.75M
Legal Settlements	-2.45M	-5.7M	-3.3M	-12.65M	-14.25M
Other Unusual Items	144M	167M	118M	110M	80.25M
EBT, Incl. Unusual Items	7.44B	9.02B	10.95B	13.01B	13.02B
Income Tax Expense	779M	1.01B	1.34B	1.43B	1.28B
Earnings From Continuing Operations	6.66B	8B	9.61B	11.58B	11.74B
Net Income to Company	6.66B	8B	9.61B	11.58B	11.74B
Minority Interest	-1.93M	-2.49M	-3.54M	3.81M	-71.48M
Net Income - (IS)	6.66B	8B	9.61B	11.58B	11.67B
Net Income to Common Incl Extra Items	6.66B	8B	9.61B	11.58B	11.67B
Net Income to Common Excl. Extra Items	6.66B	8B	9.61B	11.58B	11.67B
Per Share Items
Net EPS - Basic	5.48	6.59	7.94	9.56	9.64
Basic EPS - Continuing Operations	5.48	6.59	7.94	9.56	9.64
Basic Weighted Average Shares Outstanding	1.22B	1.21B	1.21B	1.21B	1.21B
Net EPS - Diluted	5.48	6.59	7.94	9.56	9.63
Diluted EPS - Continuing Operations	5.48	6.59	7.94	9.56	9.63
Diluted Weighted Average Shares Outstanding	1.22B	1.21B	1.21B	1.21B	1.21B
Normalized Basic EPS	3.76	4.55	5.61	6.77	6.57
Normalized Diluted EPS	3.76	4.55	5.6	6.77	6.57
Dividend Per Share	2.5	3.5	4.5	5.8	6.27
Payout Ratio	27.39	37.98	44.06	92.12	74.92
Supplemental Items
EBITDA	7.71B	9.35B	11.15B	13.13B	13.69B
EBITA	7.41B	8.98B	10.72B	12.61B	13.06B
EBIT	7.26B	8.76B	10.41B	12.26B	12.37B
EBITDAR	7.72B	9.36B	11.16B	13.14B	13.71B
Total Revenues (As Reported)	21.03B	-	30.37B	34.93B	36.73B
Effective Tax Rate - (Ratio)	10.47	11.23	12.26	11.01	9.83
Total Current Taxes	834M	1.13B	1.52B	2.08B	1.72B
Total Deferred Taxes	-55.33M	-115M	-176M	-646M	-445M
Normalized Net Income	4.57B	5.53B	6.78B	8.2B	7.95B
Interest on Long-Term Debt	-	8.63M	10.69M	12.83M	18.56M
Non-Cash Pension Expense	36.84M	12.47M	33M	84.09M	84.03M
Supplemental Operating Expense Items
Advertising Expense	243M	224M	289M	359M	332M
Selling and Marketing Expenses	3.61B	4B	4.8B	5.7B	5.28B
General and Administrative Expenses	897M	1.11B	1.32B	1.52B	1.6B
Research And Development Expense From Footnotes	1.87B	2.52B	2.92B	3.43B	3.67B
Net Rental Expense, Total	9.49M	13.16M	12.17M	15.85M	22.03M
Imputed Operating Lease Interest Expense	-	-	4.39M	6.2M	11.53M
Imputed Operating Lease Depreciation	-	-	7.78M	9.65M	10.5M
Maintenance & Repair Expenses, Total	-	-	-	-	-
Stock-Based Comp., R&D Exp. (Total)	-	-	156M	113M	-45.1M
Stock-Based Comp., S&M Exp. (Total)	-	-	125M	82.9M	-35.97M
Stock-Based Comp., G&A Exp. (Total)	-	-	27.32M	21.83M	-7.74M
Stock-Based Comp., Other (Total)	-	-	-	-	-12.75M
Total Stock-Based Compensation	-	-	308M	218M	-102M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	15.86B	15.36B	23.19B	18.79B	16.64B
Short Term Investments	-	-	-	-	-
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	15.86B	15.36B	23.19B	18.79B	16.64B
Accounts Receivable, Total	1.54B	1.79B	2.66B	3.3B	3.23B
Other Receivables	295M	91.11M	149M	195M	206M
Notes Receivable	23.93M	26.37M	31.82M	41.63M	44.31M
Total Receivables	1.86B	1.91B	2.84B	3.53B	3.48B
Inventory	3.54B	3.65B	4.02B	3.98B	4.76B
Prepaid Expenses	49.53M	145M	92.31M	60.57M	59.71M
Other Current Assets, Total	319M	271M	461M	515M	710M
Total Current Assets	21.63B	21.33B	30.61B	26.88B	25.65B
Gross Property Plant And Equipment	5.73B	7.07B	8.68B	11.05B	13.33B
Accumulated Depreciation	-1.6B	-1.93B	-2.39B	-2.83B	-3.3B
Net Property Plant And Equipment	4.13B	5.13B	6.29B	8.22B	10.03B
Long-term Investments	4.03B	4.03B	1.62B	3.09B	395M
Goodwill	1.22B	4.22B	4.4B	5.06B	11.09B
Other Intangibles, Total	1.15B	2.06B	1.98B	2.22B	6.72B
Accounts Receivable Long-Term	3.32M	34.55M	25.28M	10.94M	22.86M
Loans Receivable Long-Term	104M	99.07M	102M	125M	120M
Deferred Tax Assets Long-Term	502M	596M	755M	1.31B	1.7B
Deferred Charges Long-Term	204M	224M	379M	417M	406M
Other Long-Term Assets, Total	337M	377M	591M	604M	504M
Total Assets	33.31B	38.1B	46.75B	47.94B	56.64B
Liabilities
Accounts Payable, Total	1.5B	2.28B	2.29B	2.69B	2.79B
Accrued Expenses, Total	2.17B	2.43B	3.14B	3.14B	3.25B
Short-term Borrowings	-	-	-	7.75M	5.4M
Current Portion of Long-Term Debt	-	-	-	429K	1.16M
Current Portion of Leases	-	85.08M	97.22M	104M	114M
Current Income Taxes Payable	136M	257M	287M	472M	205M
Unearned Revenue Current, Total	3.29B	2.41B	4.14B	1.97B	2.17B
Other Current Liabilities	1.14B	1.17B	1.82B	1.72B	1.89B
Total Current Liabilities	8.24B	8.63B	11.77B	10.1B	10.43B
Long-Term Debt	-	-	-	1.38M	345K
Long-Term Leases	-	152M	139M	181M	177M
Unearned Revenue Non Current	199M	105M	92.94M	109M	127M
Deferred Tax Liability Non Current	46.62M	200M	183M	168M	809M
Other Non Current Liabilities	1.53B	2.05B	2.56B	4.03B	4.34B
Total Liabilities	10.02B	11.13B	14.75B	14.59B	15.89B
Common Stock, Total	1.22B	1.22B	1.21B	1.21B	1.21B
Additional Paid In Capital	8.15B	8.15B	7.51B	7.09B	6.75B
Retained Earnings	14.03B	18.99B	24.37B	25.29B	28.23B
Treasury Stock	-	-1B	-1B	-663M	-338M
Comprehensive Income and Other	-123M	-410M	-109M	157M	1.51M
Total Common Equity	23.28B	26.95B	31.98B	33.09B	35.86B
Minority Interest	12.75M	15.24M	18.29M	261M	4.9B
Total Equity	23.29B	26.97B	32B	33.35B	40.76B
Total Liabilities And Equity	33.31B	38.1B	46.75B	47.94B	56.64B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.22B	1.21B	1.21B	1.21B	1.21B
ECS Total Common Shares Outstanding	1.22B	1.21B	1.21B	1.21B	1.21B
Book Value / Share	19.15	22.23	26.44	27.25	29.64
Tangible Book Value	20.91B	20.67B	25.6B	25.8B	18.04B
Tangible Book Value Per Share	17.2	17.05	21.17	21.25	14.91
Total Debt	0	237M	237M	295M	298M
Net Debt	-15.86B	-15.12B	-22.95B	-18.49B	-16.35B
Debt Equivalent Oper. Leases	75.92M	105M	97.37M	127M	176M
Minority Interest, Total (Incl. Fin. Div)	12.75M	15.24M	18.29M	261M	4.9B
Equity Method Investments, Total	25.54M	26.36M	60.8M	66.56M	197M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	1.38B	1.36B	1.42B	1.53B	1.33B
Inventories - Work In Process, Total	833M	1.06B	1.18B	1.15B	1.34B
Inventories - Finished Goods, Total	1.5B	1.37B	1.65B	1.72B	2.49B
Land - (BS)	2.88B	3.26B	3.66B	4.8B	5.98B
Machinery, Total	1.92B	2.37B	2.82B	3.28B	4.15B
Full Time Employees	11.83K	-	16.1K	18.04K	21.67K
Accumulated Allowance for Doubtful Accounts (Supple)	110M	-	118M	360M	649M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	6.66B	8B	9.61B	11.58B	11.67B
Depreciation & Amortization - CF	299M	448M	537M	626M	756M
Amortization of Goodwill and Intangible Assets - (CF)	148M	219M	313M	353M	689M
Depreciation & Amortization, Total	447M	666M	849M	978M	1.44B
Amortization of Deferred Charges, Total - (CF)	36.17M	50.86M	62.07M	60.77M	58.7M
(Gain) Loss From Sale Of Asset	2.07M	-4.07M	-6.16M	-2.46M	-4.24M
(Gain) Loss on Sale of Investments - (CF)	4.47M	-10.69M	5.06M	-69.56M	-179M
Asset Writedown & Restructuring Costs	16.87M	7.47M	-	275M	1.75M
Provision and Write-off of Bad Debts	29.64M	-5.94M	36.78M	244M	299M
Other Operating Activities, Total	300M	-94.62M	-145M	33.63M	389M
Change In Accounts Receivable	-3.27M	-153M	-1.05B	-681M	-347M
Change In Inventories	-1.45B	-134M	-523M	-201M	-782M
Change In Accounts Payable	2.83B	615M	3.09B	-769M	402M
Change In Deferred Taxes	-53.63M	59.88M	-175M	-642M	-440M
Change in Other Net Operating Assets	54.29M	-	383M	254M	-78.85M
Cash from Operations	8.87B	9B	12.14B	11.06B	12.43B
Capital Expenditure	-1.18B	-1.4B	-1.92B	-2.69B	-1.96B
Sale of Property, Plant, and Equipment	2.83M	21.73M	73.33M	21.66M	30.74M
Cash Acquisitions	-	-3.52B	-	-871M	-5.77B
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-4.02B	-	-1.56B	2.69B	312M
Other Investing Activities, Total	8.75M	88.32M	180M	156M	6.92M
Cash from Investing	-5.19B	-4.81B	-3.22B	-693M	-7.38B
Long-Term Debt Issued, Total	-	-	-	-	15.14M
Total Debt Issued	-	-	-	-	15.14M
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-	-538M	-103M	-142M	-163M
Total Debt Repaid	-	-538M	-103M	-142M	-163M
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-	-1B	-1B	-6.08M	-5.4M
Common Dividends Paid	-1.82B	-3.04B	-4.23B	-10.67B	-8.74B
Common & Preferred Stock Dividends Paid	-1.82B	-3.04B	-4.23B	-10.67B	-8.74B
Other Financing Activities, Total	-29.59M	-27.71M	142M	42.47M	13.98M
Cash from Financing	-1.85B	-4.6B	-5.19B	-10.78B	-8.88B
Foreign Exchange Rate Adjustments	-197M	-171M	114M	101M	72.19M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	1.63B	-590M	3.84B	-305M	-3.76B
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	1.6B	2.07B	2.71B	3.1B	3.29B
Levered Free Cash Flow	5.72B	4.89B	7.49B	3.87B	6.56B
Unlevered Free Cash Flow	5.72B	4.89B	7.49B	3.88B	6.58B
Change In Net Working Capital	-1.88B	-101M	-1.68B	2.35B	598M
Net Debt Issued / Repaid	-	-538M	-103M	-142M	-148M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	15.4	15.34	15.33	16.19	14.79
Return on Total Capital	21.65	21.69	21.89	23.27	20.71
Return On Equity %	31.78	31.85	32.6	35.44	31.68
Return on Common Equity	31.8	31.86	32.6	35.6	33.85
Margin Analysis
Gross Profit Margin %	64.52	64.51	63.92	65.43	62.51
SG&A Margin	21.45	20.2	20.16	20.69	18.74
EBITDA Margin %	36.65	36.98	36.73	37.58	37.27
EBITA Margin %	35.23	35.55	35.31	36.11	35.57
EBIT Margin %	34.52	34.68	34.28	35.1	33.69
Income From Continuing Operations Margin %	31.67	31.67	31.65	33.15	31.97
Net Income Margin %	31.66	31.66	31.64	33.16	31.77
Net Avail. For Common Margin %	31.66	31.66	31.64	33.16	31.77
Normalized Net Income Margin	21.74	21.88	22.34	23.48	21.66
Levered Free Cash Flow Margin	27.18	19.34	24.65	11.09	17.87
Unlevered Free Cash Flow Margin	27.18	19.36	24.67	11.11	17.91
Asset Turnover
Asset Turnover	0.71	0.71	0.72	0.74	0.7
Fixed Assets Turnover	5.4	5.46	5.32	4.81	4.02
Receivables Turnover (Average Receivables)	12.97	15.17	13.64	11.71	11.23
Inventory Turnover (Average Inventory)	2.57	2.47	2.89	3.02	3.15
Short Term Liquidity
Current Ratio	2.63	2.47	2.6	2.66	2.46
Quick Ratio	2.15	2	2.21	2.21	1.93
Operating Cash Flow to Current Liabilities	1.08	1.04	1.03	1.09	1.19
Days Sales Outstanding (Average Receivables)	28.21	24.06	26.76	31.18	32.59
Days Outstanding Inventory (Average Inventory)	142.42	147.92	126.44	120.96	116.13
Average Days Payable Outstanding	57.47	76.66	73.09	75.57	68.98
Cash Conversion Cycle (Average Days)	113.16	95.32	80.11	76.57	79.74
Long Term Solvency
Total Debt/Equity	-	0.88	0.74	0.88	0.73
Total Debt / Total Capital	-	0.87	0.73	0.88	0.73
LT Debt/Equity	-	0.56	0.44	0.55	0.44
Long-Term Debt / Total Capital	-	0.56	0.43	0.54	0.43
Total Liabilities / Total Assets	30.07	29.22	31.55	30.44	28.04
EBIT / Interest Expense	-	1.01K	974.01	943.42	637.34
EBITDA / Interest Expense	-	1.09K	1.05K	1.02K	711.74
(EBITDA - Capex) / Interest Expense	-	929.71	874.24	811.83	610.81
Total Debt / EBITDA	-	0.03	0.02	0.02	0.02
Net Debt / EBITDA	-2.06	-1.6	-2.04	-1.4	-1.18
Total Debt / (EBITDA - Capex)	-	0.03	0.03	0.03	0.03
Net Debt / (EBITDA - Capex)	-2.43	-1.88	-2.46	-1.75	-1.38
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	27	20.18	20.17	15.04	5.14
Gross Profit, 1 Yr. Growth %	26.12	20.17	19.06	17.76	3.59
EBITDA, 1 Yr. Growth %	43.03	20.88	18.89	17.32	4.03
EBITA, 1 Yr. Growth %	44.29	20.86	18.91	17.26	3.29
EBIT, 1 Yr. Growth %	45.37	20.73	18.78	17.8	0.91
Earnings From Cont. Operations, 1 Yr. Growth %	42.15	20.19	20.07	20.47	1.4
Net Income, 1 Yr. Growth %	42.24	20.19	20.07	20.56	0.74
Normalized Net Income, 1 Yr. Growth %	35.56	20.96	22.71	20.9	-3.01
Diluted EPS Before Extra, 1 Yr. Growth %	42.24	20.27	20.5	20.42	0.79
Accounts Receivable, 1 Yr. Growth %	-9.21	16.32	48.62	23.9	-2.16
Inventory, 1 Yr. Growth %	56.35	0.92	12.89	-1.15	19.57
Net Property, Plant and Equip., 1 Yr. Growth %	12.83	24.28	22.57	30.71	22.06
Total Assets, 1 Yr. Growth %	29.93	14.4	22.68	2.56	18.16
Tangible Book Value, 1 Yr. Growth %	27.97	-1.12	23.84	0.77	-30.07
Common Equity, 1 Yr. Growth %	25.19	15.79	18.65	3.45	8.38
Cash From Operations, 1 Yr. Growth %	87.85	1.45	34.92	-8.89	12.38
Capital Expenditures, 1 Yr. Growth %	52.24	18.58	36.58	40.36	-27.12
Levered Free Cash Flow, 1 Yr. Growth %	131.35	-14.49	53.16	-48.25	69.58
Unlevered Free Cash Flow, 1 Yr. Growth %	131.35	-14.39	53.13	-48.19	69.53
Dividend Per Share, 1 Yr. Growth %	66.67	40	28.57	28.89	8.1
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	23.64	23.54	20.18	17.57	9.98
Gross Profit, 2 Yr. CAGR %	21.92	23.11	19.61	18.41	8.76
EBITDA, 2 Yr. CAGR %	32.62	31.71	20.1	18.29	10.61
EBITA, 2 Yr. CAGR %	33.47	32.28	20.11	18.28	10.19
EBIT, 2 Yr. CAGR %	33.88	32.48	19.75	18.29	9.03
Earnings From Cont. Operations, 2 Yr. CAGR %	33.7	30.71	20.13	20.27	10.52
Net Income, 2 Yr. CAGR %	33.79	30.75	20.13	20.31	10.21
Normalized Net Income, 2 Yr. CAGR %	32.03	28.05	21.83	21.8	8.28
Diluted EPS Before Extra, 2 Yr. CAGR %	28.05	30.8	20.39	20.46	10.17
Accounts Receivable, 2 Yr. CAGR %	-2.75	2.77	31.48	35.7	10.1
Inventory, 2 Yr. CAGR %	44.36	26.97	5.48	5.64	8.72
Net Property, Plant and Equip., 2 Yr. CAGR %	10.06	18.41	23.42	26.58	26.31
Total Assets, 2 Yr. CAGR %	24.1	21.92	18.47	12.17	10.08
Tangible Book Value, 2 Yr. CAGR %	27.4	12.49	10.66	11.71	-16.05
Common Equity, 2 Yr. CAGR %	23.92	20.4	17.21	10.79	5.89
Cash From Operations, 2 Yr. CAGR %	48.27	38.05	16.99	10.87	1.19
Capital Expenditures, 2 Yr. CAGR %	32.05	34.36	27.26	38.46	1.14
Levered Free Cash Flow, 2 Yr. CAGR %	72.5	40.65	14.44	-10.98	-6.35
Unlevered Free Cash Flow, 2 Yr. CAGR %	71.32	40.73	14.49	-10.93	-6.31
Dividend Per Share, 2 Yr. CAGR %	58.11	52.75	34.16	28.73	18.04
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	23.46	22.48	22.41	18.44	13.27
Gross Profit, 3 Yr. CAGR %	22	21.33	21.74	18.99	12.09
EBITDA, 3 Yr. CAGR %	30.31	28.73	27.44	19.3	13.42
EBITA, 3 Yr. CAGR %	31.36	29.27	27.83	19.28	13.15
EBIT, 3 Yr. CAGR %	31.7	29.35	27.74	19.09	12.18
Earnings From Cont. Operations, 3 Yr. CAGR %	36.8	29.03	27.06	20.24	13.62
Net Income, 3 Yr. CAGR %	37	29.09	27.09	20.27	13.4
Normalized Net Income, 3 Yr. CAGR %	36.1	28.23	26.25	21.52	12.89
Diluted EPS Before Extra, 3 Yr. CAGR %	32.21	25.4	27.27	20.4	13.51
Accounts Receivable, 3 Yr. CAGR %	2.65	3.23	16.21	28.9	21.68
Inventory, 3 Yr. CAGR %	31.21	29.04	21.13	3.22	10.09
Net Property, Plant and Equip., 3 Yr. CAGR %	9.96	14.61	19.78	25.81	25.05
Total Assets, 3 Yr. CAGR %	32.13	20.78	22.17	12.91	14.13
Tangible Book Value, 3 Yr. CAGR %	67.48	17.08	16.15	7.26	-4.44
Common Equity, 3 Yr. CAGR %	52.06	21.15	19.82	12.43	9.98
Cash From Operations, 3 Yr. CAGR %	39.03	30.66	37	7.64	11.38
Capital Expenditures, 3 Yr. CAGR %	36.33	27.4	35.1	31.49	11.79
Levered Free Cash Flow, 3 Yr. CAGR %	56.78	36.52	44.7	-12.16	10.34
Unlevered Free Cash Flow, 3 Yr. CAGR %	55.03	35.95	44.75	-12.1	10.36
Dividend Per Share, 3 Yr. CAGR %	-	51.83	44.22	32.38	21.45
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	21.28	22.85	22.13	20.49	17.27
Gross Profit, 5 Yr. CAGR %	22.51	23.17	21.04	20.15	16.37
EBITDA, 5 Yr. CAGR %	47.27	42.08	26.21	24.54	20.5
EBITA, 5 Yr. CAGR %	52.88	44.53	26.82	24.85	20.54
EBIT, 5 Yr. CAGR %	52.26	43.81	26.78	24.8	19.9
Earnings From Cont. Operations, 5 Yr. CAGR %	47.92	37.78	29.87	25.45	20.17
Net Income, 5 Yr. CAGR %	48.89	37.97	29.98	25.51	20.04
Normalized Net Income, 5 Yr. CAGR %	39.38	38.47	30.2	25.62	18.73
Diluted EPS Before Extra, 5 Yr. CAGR %	41.08	32.55	27.34	23.4	20.13
Accounts Receivable, 5 Yr. CAGR %	4.5	11.23	13.34	15.17	13.73
Inventory, 5 Yr. CAGR %	28.73	28.77	20.76	18.55	16
Net Property, Plant and Equip., 5 Yr. CAGR %	7.48	11.52	15.16	19.25	22.35
Total Assets, 5 Yr. CAGR %	21.92	24.04	26.49	17.26	17.18
Tangible Book Value, 5 Yr. CAGR %	38.06	55.26	41.89	14.9	2
Common Equity, 5 Yr. CAGR %	29.57	42.92	37.03	16.9	14.04
Cash From Operations, 5 Yr. CAGR %	34.38	24.24	29.76	22.35	21.36
Capital Expenditures, 5 Yr. CAGR %	14.71	27.67	32.63	31.71	20.33
Levered Free Cash Flow, 5 Yr. CAGR %	45.6	36.02	38.23	15.06	21.59
Unlevered Free Cash Flow, 5 Yr. CAGR %	44.78	34.99	37.33	14.79	21.63
Dividend Per Share, 5 Yr. CAGR %	-	-	-	42.13	33.12